15 results
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
Treatment • Invasive pulmonary ... eye Infectious Diseases ... Aspergillosis #Treatment #management ... #pharmacology # ... IDSA
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease ... Mycobacterium tuberculosis ... complex (MAC) disease ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease ... Mycobacterium tuberculosis ... complex (MAC) disease ... #management #pharmacology
Leptospirosis
Pathogen: Leptospira (interrogans, kirschneri, noguchii)
Risk Factors:
 • Occupational exposure - Farmers, ranchers, trappers, veterinarians
 • Recreational
Leptospirosis Pathogen ... failure • Severe pulmonary ... disease ARDS Diagnosis ... #microbiology #diagnosis ... #treatment #management
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Pott's Disease in ... Diagnosis and Management ... symptoms of active pulmonary ... for concomitant pulmonary ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Chronic kidney disease ... Disease Progression ... Diagnosis: Latent ... #TB #Diagnosis ... #Management #Treatment
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Failure, Valvular Disease ... Pericardial tamponade, Pulmonary ... vasoactive drug pharmacology ... #inopressors #diagnosis ... #management #comparison
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Chronic kidney disease ... Disease Progression ... Diagnosis: Latent ... #TB #Diagnosis ... #Management #Treatment
Causes of Fatigue - Differential Diagnosis Algorithm
Endocrine
 • Hypo/Hyperthyroidism
 • Diabetes
 • Pituitary Insufficiency
 • Adrenal
- Differential Diagnosis ... Endocarditis • Tuberculosis ... Chronic Obstructive Pulmonary ... Disease Neurologic ... Myasthenia Gravis Pharmacologic
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... children with TB disease ... #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #